Targeted reduction of CCR4+ cells is sufficient to suppress allergic airway inflammation

Respiratory Investigation

Volumn 51, Issue 4, 2013, Pages 241-249

  Honjo, Akifumi ^a   Ogawa, Hirohisa ^a   Azuma, Masahiko ^a   Tezuka, Toshifumi ^a   Sone, Saburo ^a   Biragyn, Arya ^b   Nishioka, Yasuhiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Airway hyperresponsiveness; Allergic inflammation; Bronchial asthma; CCR4; TARC PE38

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIAL TOXIN; CHEMOKINE RECEPTOR CCR4; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; THYMUS AND ACTIVATION REGULATED CHEMOKINE PE38 FUSION PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EOSINOPHIL; FEMALE; GOBLET CELL; HISTOPATHOLOGY; HOUSE DUST ALLERGY; LEUKOCYTE COUNT; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; TH1 CELL; TH2 CELL;

AIRWAY HYPERRESPONSIVENESS; ALLERGIC INFLAMMATION; BALF; BOVINE SERUM ALBUMIN; BRONCHIAL ALVEOLAR LAVAGE FLUID; BRONCHIAL ASTHMA; BSA; C-C CHEMOKINE RECEPTOR TYPE 4; CCR4; CHEMOKINE-LIKE FACTOR 1; CKLF1; DERMATOPHAGOIDES PTERONYSSINUS; DP; H&E; HDM; HEMATOXYLIN AND EOSIN; HOUSE DUST MITE; IFN; INTERFERON; LUNG RESISTANCE; MACROPHAGE-DERIVED CHEMOKINE; MCH; MDC; METHACHOLINE; PAS; PERIODIC ACID SCHIFF; R(L); TARC; TARC-PE38; THYMUS AND ACTIVATION-REGULATED CHEMOKINE;

AIRWAY RESISTANCE; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHEMOKINE CCL17; DISEASE MODELS, ANIMAL; EXOTOXINS; FEMALE; IMMUNOGLOBULIN E; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; PYROGLYPHIDAE; RECEPTORS, CCR4; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 84887628568     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2013.04.007     Document Type: Article

References (25)

1. Antoniu SA. Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema. Curr Opin Invest Drugs 2010, 11:1286-1294.
2. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009, 360:973-984.
3. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-134.
4. Imai T, Baba M, Nishimura M, et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997, 272:15036-15042.
5. Imai T, Chantry D, Raport CJ, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998, 273:1764-1768.
6. Wang Y, Zhang Y, Yang X, et al. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4). Life Sci 2006, 78:614-621.
7. + T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 2001, 107:353-358.
8. + T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001, 117:188-196.
9. Panina-Bordignon P, Papi A, Mariani M, et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001, 107:1357-1364.
10. Perros F, Hoogsteden HC, Coyle AJ, et al. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 2009, 64:995-1002.
11. Baatar D, Olkhanud P, Newton D, et al. CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors. J Immunol 2007, 179:1996-2004.
12. Olkhanud PB, Baatar D, Bodogai M, et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res 2009, 69:5996-6004.
13. Ogawa H, Azuma M, Muto S, et al. IkappaB kinase beta inhibitor IMD-0354 suppresses airway remodelling in a dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clin Exp Allergy 2011, 41:104-115.
14. Sugita A, Ogawa H, Azuma M, et al. Antiallergic and anti-inflammatory effects of a novel I kappaB kinase beta inhibitor, IMD-0354, in a mouse model of allergic inflammation. Int Arch Allergy Immunol 2009, 148:186-198.
15. + Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J Immunol 2007, 178:4891-4900.
16. + T cells. Respirology 2006, 11:152-157.
17. Morgan AJ, Symon FA, Berry MA, et al. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol 2005, 116:594-600.
18. Liddiard K, Welch JS, Lozach J, et al. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol 2006, 7:45.
19. Mikhak Z, Fukui M, Farsidjani A, et al. Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. J Allergy Clin Immunol 2009, 123:67-73 e3.
20. Tsunemi Y, Saeki H, Nakamura K, et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 2006, 36:2116-2127.
21. Dasgupta P, Keegan AD. Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. J Innate Immun 2012, 4:478-488.
22. Lehner T. Special regulatory T cell review: the resurgence of the concept of contrasuppression in immunoregulation. Immunology 2008, 123:40-44.
23. Taniguchi M, Harada M, Kojo S, et al. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003, 21:483-513.
24. Akbari O, Stock P, Meyer E, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003, 9:582-588.
25. Meyer EH, Wurbel MA, Staton TL, et al. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol 2007, 179:4661-4671.